A Case of Mirizzi’s Syndrome Mimicking Carcinoma: The Role of CBD-Stenting for Easy Surgical Management

Psarras, Kyriakos; Ballas, Konstantinos; Pavlidis, Theodosios; Rafailidis, S.; Symeonidis, Nikolaos; Marakis, Georgios; Sakantamis, Athanasios K.

doi:10.1089/lap.2008.0281

Cited by 2 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our cases, a false diagnosis of cancer occurred in 39% of cases (7/18) explainable by the onset of jaundice in the absence of painful symptoms. The risk of bile duct injury during cholecystectomy for Mirizzi syndrome is increased according to the literature [ 14 ]. This fact is consequent to the anatomical difficulties during the dissection of the Calot's triangle.…”

Section: Discussionmentioning

confidence: 99%

Mirizzi Syndrome: Diagnosis and Management of a Challenging Biliary Disease

Clemente

Tringali²,

Rose

et al. 2018

Canadian Journal of Gastroenterology and Hepatology

View full text Add to dashboard Cite

Background Mirizzi syndrome is a condition difficult to diagnose and treat, representing a particular “challenge” for the biliary surgeon. The disease can mimic cancer of the gallbladder, causing considerable diagnostic difficulties. Furthermore, it increases the risk of intraoperative biliary injury during cholecystectomy. The aim of this study is to point out some particular aspects of diagnosis and treatment of this condition. Methods The clinical records of patients with Mirizzi syndrome, treated in the last five years, were reviewed. Clinical data, cholangiograms, preoperative diagnosis, operative procedures, and early and late results were examined. Results Eighteen consecutive patients were treated in the last five years. Presenting symptoms were jaundice, pain, and cholangitis. Preoperative diagnosis of Mirizzi syndrome was achieved in 11 patients, while 6 had a diagnosis of gallbladder cancer and 1 of Klatskin tumor. Seventeen patients underwent surgery, including cholecystectomy in 8 cases, bile duct repair over T-tube in 3 cases, and hepaticojejunostomy in 4 cases. Two cases (11.1%) of gallbladder cancer associated with the Mirizzi syndrome were incidentally found: a patient underwent right hepatectomy and another patient was unresectable. The overall morbidity rate was 16.6%. There was no postoperative mortality. An ERCP with stent insertion was required in three cases after surgery. Sixteen patients were asymptomatic at a mean distance of 24 months (range: 6-48) after surgery. Conclusions Mirizzi syndrome requires being treated by an experienced biliary surgeon after a careful assessment of the local situation and anatomy. The preoperative placement of a stent via ERCP can simplify the surgical procedure.

show abstract

Section: Discussionmentioning

confidence: 99%